IME

0.00%

48.0¢ imexhs limited

Ann: Quarterly Cash Flow and Summary of Activities, page-43

First 43 Last

Share
Profile

Follow
TitusPullo

4,696 Posts.

72

23/10/19

15:09

Post #: 41032784
Share

Originally posted by Just_a_guy ↑

i was initially very interested in ime because of South America/developing world.
They have a clear first mover advantage in South America and as the presentation suggests, they are replacing archaic systems including wet film. This provides a great tailwind.

So why on earth are they wasting time and money on aus and America? They don’t have a hope of competing in those markets. The cost of pacs/ris for a radiology clinic is a tiny tiny fraction of revenue in developed countries, and therefore radiology providers are going to favour efficiency over cost (except sometimes in the public health sector in aus but care stream and cdn are competitors in that space too). So ime trying to undercut their bigger competitors who have more scale means they are up against an impossible task in my view. They can’t be the most functional or efficient provider because the r&d spend of their competitors is many multiples of ime’s revenue.

Cybically, i think they are signing up a hicksville mobile ultrasound company in aus and applying for fda to help their share price to help them raise capital.

so that brings us back to South America. I think ime has a chance of doing very well if their product is reasonable (which I highly doubt given that they were touting ‘new cross referencing ability’ 12 months ago, which is a feature that the better provider have been providing for more then a decade).
If they can keep signing up hospitals in South America and the developing world while the big competitors concentrate on the growing developed world, then they will do well. But the second a better competitor comes along, due to scalability of the software which is increasing by the year, I believe ime will be cactus, and I don’t think carestream/pme/intelerad will need to bother buying ime.

Having said that there is every chance ime 5bags prior, but I just don’t think they have a long term business, and buying this hoping a competitor buys them is rarely a strategy for success.

Expand

Found the webcast. Also refer to being able to increase the prices in SA

Question asked from the 22 min asked re soft launches in the USA and Oz

http://www.openbriefing.com/OB/IMEX...t-Quarter-2019-Appendix-4C-results-/3322.aspx

IME Price at posting: 4.1¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 89 more messages in this thread...

First 43 Last

Add IME (ASX) to my watchlist

(20min delay)
Last 48.0¢		Change 0.000(0.00%)		Mkt cap ! $21.89M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	10000	45.0¢

Sellers (Offers)

Price($)	Vol.	No.
49.0¢	30767	2

View Market Depth

No.	Vol.	Price($)
1	10000	0.450
2	26200	0.400
1	1390	0.360
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.490	30767	2
0.500	50000	1
0.510	3000	1
0.530	24000	1
0.560	18000	1

Last trade - 16.12pm 27/09/2024 (20 minute delay)

IME (ASX) Chart

Day chart unavailable

Ann: Quarterly Cash Flow and Summary of Activities, page-43

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Cash Flow and Summary of Activities, page-43

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News